Rosacea, Papulopustular study: KTP Laser Therapy vs Radiofrequency microneedling
Official title Rosacea Radiofrequency Microneedling
ClinicalTrials.gov ID: NCT06801717
What this study is testing
- What it's testing
- The study will see how well radiofrequency microneedling works for these rosacea types, whether adding a 532‑nm KTP laser helps, and if new treatment ideas can be found.
- Who it's for
- Adults who have either erythematotelangiectatic or papulopustular rosacea.
- What's involved
- Participants will receive radiofrequency microneedling treatments, and some may also get a 532‑nm KTP laser as part of the study.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Male or female adult (\>18yo) people in general good health
- Clinical and/or histologic diagnosis of erythematotelangiectatic or papulopustular rosacea.
- Subject is able to understand and sign informed consent
- Subject is able to complete the study and comply with study procedures
You likely can't join if
- Patients currently utilizing oxymetazoline or brimonidine.
- Presence of dermatoses that might interfere with diagnosis as determined by a study investigator
- Presence of extreme light sensitivity, or conditions pre-disposing to light sensitivity such as but not limited to xeroderma pigmentosum
- Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
- History of poor wound healing or blood-clotting abnormality
- History of keloid formation or hypertrophic scarring
See the full eligibility criteria
- Male or female adult (\>18yo) people in general good health
- Clinical and/or histologic diagnosis of erythematotelangiectatic or papulopustular rosacea.
- Subject is able to understand and sign informed consent
- Subject is able to complete the study and comply with study procedures
- Patients currently utilizing oxymetazoline or brimonidine.
- Presence of dermatoses that might interfere with diagnosis as determined by a study investigator
- Presence of extreme light sensitivity, or conditions pre-disposing to light sensitivity such as but not limited to xeroderma pigmentosum
- Any significant medical condition that may prevent the patient from participating in the study according to the investigator's assessment
- History of poor wound healing or blood-clotting abnormality
- History of keloid formation or hypertrophic scarring
- Hypersensitivity or contraindication to local anesthetics as determined by the principal investigator or other medical professional.
- Prisoners
The study team makes the final eligibility decision.
Where it is enrolling
- Miami Beach, Florida, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Miami Beach, Florida, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.